PROPHECY Study home

COVID-19 vaccines protect against severe disease. However, people with underlying health conditions remain at risk of infection and associated complications. The PROPHECY study will evaluate antibodies and cellular immune responses after infection or vaccination in healthy and vulnerable people to evaluate their protection against future variants. These findings will inform future clinical care for COVID-19 and targeted approaches to enhance vaccine responses in vulnerable patient groups.

Join the study Now recruiting participants Click here.